Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/GUFIC-BIOSCIENCES-LIMITED-46728950/news/Lumosa-Therapeutics-Co-Ltd-genehmigt-die-exklusive-Lizenzvereinbarung-mit-Gufic-Biosciences-fur-45317096/?utm_source=whatsapp&utm_medium=social&utm_campaign=share